Navigation Links
Statement From The National Conclave on HIV/AIDS Policy for Black Clergy

Clergy Statement and National HIV/AIDS Elimination Act

NEW YORK, Oct. 10 /PRNewswire/ -- In the spirit of our historic role of advancing prophetic social justice ministry, Black clergy are stepping forward to play a stronger leadership role in advocating for theologically sound HIV/AIDS public policy. Working with the National Black Leadership Commission on AIDS (NBLCA), we are determined to live up to the biblical mandate that calls us to be "the light of the world." With faithfulness to this calling, we must compassionately embrace those who are infected with and affected by HIV/AIDS. Through life-affirming ministry, we are committed to caring for the physical, mental and spiritual needs of all people in our communities whose lives are being devastated by this insidious disease.

Just as African American clergy fervently came together 50 years ago to fight for civil rights, we are banning together today to bring an end to HIV/AIDS and its potential to obliterate our community. To combat this plague, which is claiming five to seven thousand lives per day worldwide and is destroying Black families and killing Black men and women at a disproportionate rate of genocidal magnitude:

-- We will aggressively seek to have every person under the sphere of our

influence tested for HIV in order to know their status.

-- We will promote HIV/AIDS awareness to insure that all Black clergy

serving in our denominations and other congregations are equipped to

address issues related to this disease in a factual and scientifically

sound manner.

-- We will use the ABC/D model as a behavioral guideline for prevention


A ---- Abstain

B ---- Be Faithful

C ---- Use Condoms

D ---- Don't Engage In Risky Behavior

To ensure that we are jointly using our resources to influence and impact public policy, our proposed legislative action, the National HIV/AIDS Elimination Act, is as follows:

-- The National Conclave on HIV/AIDS for Black Clergy calls upon the

President, Congress and Corporate America to declare the HIV/AIDS

crisis in the African American community a "public health emergency."

We call on the Secretary of Health and Human Services to use emergency

authority to redirect resources to address this emergency.

-- We believe the United States should develop a National AIDS Plan to

address the treatment, care, prevention, research and supportive

service needs of Americans living with and at risk for HIV/AIDS.

-- We believe that an integral component of any National AIDS Plan should

be targeted legislation that specifically addresses the

disproportionate impact of HIV/AIDS on the African Americans.

Therefore, we call on Congress and the Administration to endorse and

pass the National HIV/AIDS Elimination Act - legislation that will

mobilize action across departments of government and coordinate

programs and funding across the various agencies within the Department

of Health and Human Services. The Act will include measurable goals,

timetables and specific objectives designed to eliminate the HIV/AIDS

epidemic. As a part of the National AIDS Plan, the Elimination Act will

highlight and address the key structural drivers of the AIDS epidemic,

like poverty, low literacy, stigma, unemployment, incarceration, racial

disparities and other structural drivers of the epidemic in the United


-- The Elimination Act will establish an institute to document the

historical treatment of African Americans and its impact on the issues

that have evolved and must be addressed. All agencies of the government

should be involved in making this a priority.

-- We endorse HR 1943 Stop AIDS in Prison Act (sponsored by Congresswoman

Maxine Waters, (D-Los Angeles CA) that requires routine HIV testing

upon entry and exit, counseling and HIV/AIDS treatment for federal

inmates when medically indicated and linkage to care upon discharge.

As we go forward on this historic gathering, we are determined to stand together in a renewed effort to realize the day when the "face of AIDS" will cease to be the faces of the Black community.

SOURCE The National Conclave
Copyright©2007 PR Newswire.
All rights reserved

Related medicine technology :

1. Lupus Foundation of America Statement on Results for Clinical Study of CellCept Released by Aspreva Pharmaceutical Company
2. Obama Statement on Bush Veto of Stem Cell Bill
3. Statement by Philip Home Chairman of the RECORD Study Steering Committee and Professor of Diabetes Medicine at Newcastle University in England
4. New Position Statement from The North American Menopause Society Addresses Use of Local Estrogen for Treatment of Vaginal Atrophy in Postmenopausal Women
5. Phase 3 Results for Dabigatran Etexilate, an Investigational Oral Anticoagulant, Presented Today at the XXIst Congress of the International Society on Thrombosis and Haemostasis
6. Neose Announces Presentation of Positive Preclinical Data on GlycoPEGylated Factor VIIa at the XXI Congress of the International Society on Thrombosis and Haemostasis
7. Inspiration Biopharmaceuticals Presents Data From Hemophilia Program at International Society On Thrombosis and Haemostasis (ISTH) Annual Meeting
8. Portola Pharmaceuticals Announces Positive Data from a Phase II Study of its Factor Xa Inhibitor at the XXI Congress of the International Society on Thrombosis and Haemostasis
9. International ENDORSE Study Shows That the Majority of Hospitalized Patients Surveyed are at Risk for VTE and Many do not Receive Recommended VTE prophylaxis
10. New Drugs in Multinational Study Show Promise in Fighting Drug-Resistant HIV
11. Suven Life Sciences Presenting Pre-clinical data of their NCE’s SUVN-502 and SUVN-507at International Brain Research Organization (IBRO) 2007 World Congress of Neuroscience
Post Your Comments:
(Date:11/25/2015)... LYON , Frankreich, November 25, 2015 ... hat heute bekanntgegeben, dass sie eine Lizenz für das ... Inserm, Poxel, CNRS, UCBL und ENS-Lyon innehaben, an Enyo ... 2009 von FUI AAP8 ins Leben gerufenen und von ... NATHEB-Programms wurde FXR als ein Behandlungsziel für HBV identifiziert, ...
(Date:11/24/2015)... WuXi PharmaTech (Cayman) Inc. ("WuXi" or the "Company") (NYSE: ... technology platform company serving the pharmaceutical, biotechnology, and medical ... and the United States , ... shareholders held today, the Company,s shareholders voted in favor ... announced agreement and plan of merger (the "Merger Agreement") ...
(Date:11/24/2015)... BOULDER, Colo. , Nov. 24, 2015 /PRNewswire/ ... announced that its Chief Executive Officer, Ron ... Annual Healthcare Conference in New York.  The public ... a webcast on the Array BioPharma website.Event:Piper Jaffray ... OfficerDate:  , Wednesday, December 2, 2015Time:1:30 p.m. Eastern ...
Breaking Medicine Technology:
(Date:11/24/2015)... ... November 25, 2015 , ... Catalent Pharma Solutions, ... biologics, consumer health and global clinical supply services, today announced that Dr. Christine ... Supply East Asia Conference, to be held at the InterContinental Seoul COEX Hotel, ...
(Date:11/24/2015)... (PRWEB) , ... November 24, 2015 , ... Preparing for ... p.m. – 3:00 p.m. EST, , FDA has long asserted that ... regulations apply to performing the tests and do not meet the device regulations. , ...
(Date:11/24/2015)... ... November 24, 2015 , ... ... Bolier Reactor System. Brillouin is the developer of renewable energy technologies capable of ... nuclear reactions (“LENR”), announced today that its WET™ and HHT™ Boiler System reactor ...
(Date:11/24/2015)... (PRWEB) , ... November 24, 2015 , ... ... gather to share their knowledge and experiences at a live taping of the ... Ruesch Center for the Cure of Gastrointestinal Cancers 2015 Symposium at Georgetown University ...
(Date:11/24/2015)... ... November 24, 2015 , ... Serenity Point Rehabilitation, a ... of recent video interviews with some of the staff members at their recovery center. ... treatment facility, as well as some of the things that make their recovery program ...
Breaking Medicine News(10 mins):